Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC strep test?

Executive Summary

Becton Dickinson acquires U.S. marketing rights to a dipstick strep test which could be an entry to the OCT market. The test, developed by Quidel of La Jolla, California, will initially be markedted in traditional fashion to MDs. An application to FDA's medical devices and diagnostics regulatory section is currently pending for an OTC version. B-D is also getting marketing rights to dipstick pregnancy and ovulation tests from Quidel. B-D is acquiring a less than 12% interest in Quidel.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS009270

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel